Search research articles
Contact Us
Filters
Showing results (11-20 of 27) with videos related to
Page
of 3
Sort By:
American Journal of Ophthalmology
|
August 23, 2008
QuantiFERON TB-Gold--a new test strengthening long-suspected tuberculous involvement in serpiginous-like choroiditis
Friederike Mackensen, Matthias D Becker, Ute Wiehler, et al.
Autoimmunity
|
October 9, 2009
Apototic cell-derived membrane vesicles induce CD83 expression on human mdDC
Eva-Marie Fehr, Sonja Kierschke, Regina Max, et al.
Rheumatology (Oxford, England)
|
November 26, 2013
Oral status in patients with early rheumatoid arthritis: a prospective, case-control study
Björn Wolff, Timo Berger, Cornelia Frese, et al.
The Journal of Rheumatology
|
June 3, 2016
Rituximab in the Treatment of Jo1 Antibody-associated Antisynthetase Syndrome: Anti-Ro52 Positivity as a Marker for Severity and Treatment Response
Jutta Bauhammer, Norbert Blank, Regina Max, et al.
Ocular Immunology and Inflammation
|
July 21, 2011
Difficulties of interpreting Borrelia serology in patients with uveitis
Friederike Mackensen, Stefan Zimmermann, Werner Alle, et al.
Ocular Immunology and Inflammation
|
December 30, 2017
Randomized Controlled Study to Evaluate the Efficacy of Adalimumab in Patients with Different Forms of Refractory Uveitis
Friederike Mackensen, Carsten Heinz, Eva Jakob, et al.
The Journal of Rheumatology
|
November 19, 2013
Experiences with rituximab for the treatment of autoimmune diseases with ocular involvement
Laura Pelegrin, Eva Jakob, Annette Schmidt-Bacher, et al.
The British Journal of Ophthalmology
|
December 6, 2012
A three-centre experience with adalimumab for the treatment of non-infectious uveitis
Bianca Carola Dobner, Regina Max, Matthias D Becker, et al.
The Journal of Rheumatology
|
January 10, 2009
Uveitis subtypes in a german interdisciplinary uveitis center--analysis of 1916 patients
Eva Jakob, Mirjam S Reuland, Friederike Mackensen, et al.
Medizinische Klinik (Munich, Germany : 1983)
|
February 4, 2010
[In Process Citation]
Christoph Fiehn, Regina Max, Norbert Blank, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 27) with videos related to
Sort By:
Page
of 3
American Journal of Ophthalmology
|
August 23, 2008
QuantiFERON TB-Gold--a new test strengthening long-suspected tuberculous involvement in serpiginous-like choroiditis
Friederike Mackensen, Matthias D Becker, Ute Wiehler, et al.
Autoimmunity
|
October 9, 2009
Apototic cell-derived membrane vesicles induce CD83 expression on human mdDC
Eva-Marie Fehr, Sonja Kierschke, Regina Max, et al.
Rheumatology (Oxford, England)
|
November 26, 2013
Oral status in patients with early rheumatoid arthritis: a prospective, case-control study
Björn Wolff, Timo Berger, Cornelia Frese, et al.
The Journal of Rheumatology
|
June 3, 2016
Rituximab in the Treatment of Jo1 Antibody-associated Antisynthetase Syndrome: Anti-Ro52 Positivity as a Marker for Severity and Treatment Response
Jutta Bauhammer, Norbert Blank, Regina Max, et al.
Ocular Immunology and Inflammation
|
July 21, 2011
Difficulties of interpreting Borrelia serology in patients with uveitis
Friederike Mackensen, Stefan Zimmermann, Werner Alle, et al.
Ocular Immunology and Inflammation
|
December 30, 2017
Randomized Controlled Study to Evaluate the Efficacy of Adalimumab in Patients with Different Forms of Refractory Uveitis
Friederike Mackensen, Carsten Heinz, Eva Jakob, et al.
The Journal of Rheumatology
|
November 19, 2013
Experiences with rituximab for the treatment of autoimmune diseases with ocular involvement
Laura Pelegrin, Eva Jakob, Annette Schmidt-Bacher, et al.
The British Journal of Ophthalmology
|
December 6, 2012
A three-centre experience with adalimumab for the treatment of non-infectious uveitis
Bianca Carola Dobner, Regina Max, Matthias D Becker, et al.
The Journal of Rheumatology
|
January 10, 2009
Uveitis subtypes in a german interdisciplinary uveitis center--analysis of 1916 patients
Eva Jakob, Mirjam S Reuland, Friederike Mackensen, et al.
Medizinische Klinik (Munich, Germany : 1983)
|
February 4, 2010
[In Process Citation]
Christoph Fiehn, Regina Max, Norbert Blank, et al.
Page
of 3